Immediate Impact
1 by Nobel laureates 56 standout
Citing Papers
Interstitial Lung Disease
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Kenta Yagi being referenced
Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kenta Yagi | 112 | 91 | 28 | 138 | 59 | 490 | |
| Jia Wang | 78 | 93 | 16 | 142 | 50 | 486 | |
| Arash Ghasemi | 93 | 55 | 21 | 111 | 38 | 484 | |
| Cemil Bilir | 85 | 131 | 22 | 168 | 48 | 536 | |
| Jun Luo | 141 | 83 | 48 | 174 | 48 | 498 | |
| Xinyu Liu | 112 | 71 | 22 | 207 | 45 | 504 | |
| Dan Zhang | 93 | 99 | 36 | 215 | 41 | 563 | |
| Konrad Zaręba | 66 | 125 | 13 | 156 | 46 | 420 | |
| Takeshi Kotake | 103 | 109 | 34 | 100 | 57 | 436 | |
| Massood Hosseinzadeh | 62 | 60 | 28 | 107 | 61 | 569 | |
| Xin Su | 98 | 61 | 24 | 263 | 34 | 502 |
All Works
Login with ORCID to disown or claim papers
Loading papers...